Active	Status	Sponsor type	Region	Phase	Filter
13 Active 14 Inactive 27 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kreitman, Robert
NCT03340506 / 2017-001987-39: Dabrafenib and/or Trametinib Rollover Study	Recruiting	4	100	Europe, Japan, US, RoW	dabrafenib, trametinib	Novartis Pharmaceuticals	Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma	12/27	12/27